Resistant Hypertension in Hemodialysis Patients

Title: Resistant Hypertension in Hemodialysis Patients

Authors: Ahmad B. Elden, Walaa H. Mohamad, Muhammad Hosam Magraby

DOI: http://dx.doi.org/10.18535/jmscr/v4i6.17

Abstract

References

Corresponding Author

Abstract

Objectives: This study aimed to assess prevalence of resistant hypertension (RHT) in hemodialysis (HD) patients.

Patients and Methods: We conducted a cross sectional study on 135 HD patients. RHT was defined as failure to reach target blood pressure (BP) control (systolic BP <140 mmHg and diastolic BP < 90 mmHg) with maximal dose of 3 antihypertensive therapies (AHT) including diuretics in patients with good daily urine output (> 500 cc/day) or at least 2 L/session ultra filtration volume in oliguric (<500-100 cc/day) or anuric patients (< 50 cc /day). Patients with post HD hypertension underwent 24h ambulatory monitor for their BP, which hourly measured their BP.

Results: In our study; 34 (25.2%) of patients were non hypertensives, 43 (31.8%) were controlled hypertensives, 58 (43.0%) were uncontrolled hypertensives. Uncontrolled hypertensives with inadequate AHT were 53 (39.2 %), where RHT patients were 5 (3.7%) of all study population.

Conclusions: We concluded that RHT had3.7% prevalence in HD patients.

Keywords: resistant hypertension, haemodialysis.

References

1- Venkata C., RamS. and Andrew Z. Fenves: Management of Hypertension in Hemodialysis Patients. Current Hypertension Reports 2009, 11:292–98

2- Calhoun DA, Jones D, Textor S, et al: Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008;51(6):1403-19.

3- Heerspink HJL, Ninomiya T, Zoungas S, de Zeeuw D, Grobbee DE and Jardine MJ, et al: Effect of lowering blood pressureon cardiovascular events and mortality in patients on dialysis:A systematic review and meta-analysis of randomised controlledtrials. Lancet 2009; 373: 1009-15.

4- Henrich WL and Lionel U. Mailloux: In: Schwab SJ, et al. eds. Hypertension in hemodialysis patients. Waltham, MA: Up to Date2013.

5- Daugherty S.L., Powers J.D. and Magid D.J:Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012;125:1635-42.

6- Bargman JM, Thorpe KE and Churchill DN: Relative contribution of residual renal functionand peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSAstudy. Journal of American Society of Nephrology 2001, 12 (10): 2158-62.

7- Konings CJ, Kooman JP, Schonck M, Struijk DG, Gladziwa U, Hoorntje SJ, van der Wall Bake AW, van der Sande FM and Leunissen KM: Fluid status in CAPD patients isrelated to peritoneal transport and residual renal function: Evidence from alongitudinal study. Nephrology Dialysis Transplant 2003; 18(4): 797-803

8- Wang AY, Wang M, Woo J, Lam CW, Lui SF, Li PK and Sanderson JE: Inflammation, residual renal function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. Journal of American Society of Nephrology2004, 15(8): 2186-94.

9- Pecoits-Filho R, Heimburger O, Barany P, Barany P, Suliman M, Fehrman-Ekholm I, Lindholm B and Stenvinkel P: Associations between circulating inflammatorymarkers and residual renal function in CRF patients. American Journal of Kidney Disease 2003,41(6): 1208-12.

10- Jeffrey Thomas and Isaac Teitelbaum: Preservation of Residual Renal Function in Dialysis Patients.Advances in Peritoneal Dialysis 2011; 27.

11- Rahman M, Dixit A, Donley V, Gupta S, Hanslik T, Lacson E, Ogundipe A, Weigel K and Smith MC:Factors associated with inadequate blood pressure control in hyperte-nsive hemodialysis patients.American Journal of Kidney Disease 1999, 33(3):498-506.

12- Nabela Enam, Kavita Kakkad, Akshay Amin and Carole Lever:Management of hypertension in the hemodialysispopulation: a review of the literature. Journal of Community Hospital Internal Medicine Perspectives. 2014; 4(3): 10.3402/jchimp.v4.24055.

Call For Paper Volume 12 Issue 12 December 2024

The JMSCR is accepting manuscripts for its coming issues to be Publish Volume 12 Issue 12 December 2024 the JMSCR invites authors to submit manuscripts Reporting original medical research, original article, research article, case report, systematic reviews, or educational Innovations for publication for the coming issues that will be released in Volume 12 Issue 12 December 2024. Types of manuscripts suitable for JMSCR include: Medical research, Clinical research Educational Innovation, Brief Report, Reviews on Teaching In keeping with high quality scholarship, Read More.....

https://jmscr.igmpublication.org/ems/index.php/jmscr/about/submissions

If any difficulty you can also submit to: This email address is being protected from spambots. You need JavaScript enabled to view it.

JMSCR Menu

Impact Factor SJIF 2024: 7.892

https://sjifactor.com/passport.php?id=1725

Crossref - DOI

Crossref - DOI Prefix: 10.18535/jmscr

Editorial Policy

Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not ..

Frequency of Publication

JMSCR is published as monthly journal with 12 issues per year. Special editions are also planned subjected to the scope and need....

Submission of Articles

Authors are invited to submit their research articles, review papers, Case Report properly formatted as per the author guidelines.........

Search

Abstract